Optimapharm has acquired MKS Research as it plans to double its revenue and become the largest independent contract research organization (CRO) in the Central and Eastern Europe (CEE) and South East Europe (SEE) regions.
Reluctant doctors and varying reimbursement policies are affecting biosimilar trial recruitment, experts said at the European Generics Association’s biosimilars conference in London last week.
With operations across 19 European countries as well as the US, contract Research Organization KCR recently relocated its head office from Warsaw, Poland, to Berlin, Germany to be closer to clients.
Germany-based full-service CRO (contract research organization) Accovion has expanded European presence with new offices in Italy, France and Eastern Europe.
CRO Harlan Laboratories, has expanded its specialty research production facility in southern Europe to provide its complete portfolio of contract breeding and health monitoring services to clients in Europe.
Synexus has agreed to acquire Clinpharm, giving it access to 10 clinical trial sites in Germany, Austria and Ukraine and increasing its patient population reach in Europe by 100 per cent.
US clinical trials firm ChemDiv has bought Russian CRO Prudentas, boosting its presence in the country at a time when the treatment naïve populations in Eastern Europe are increasingly catching the eye of the global pharma and biotech industries.
LGC Standards is increasing its presence in Asia through the opening of its first office in China, which will provide laboratory quality management services to the local market.
Synexus' new trial site in Bulgaria, which is part of the firm’s clinical research centre strategy, will help sponsors cut development times and significantly reduce costs, according to CEO Michael Fort.
PPD has reached an agreement to buy AbCRO, which it hopes will strengthen its position in the thriving Central and Eastern European (CEE) clinical trials scene.
Chiltern has become the latest in a growing number of contract
research organisations (CROs) to establish a foothold within the
clinical sleeping giant that is Russia.
Despite all the hype over clinical trial offshoring, the US still
dwarfs the scene, with emerging countries as yet only a blip on the
radar, a unique new study reveals.
A Polish and a Czech firm have merged together in a bid to
strengthen their position in the Central and Eastern Europe's
(CEE's) budding clinical research scene.
Movianto has more than doubled its pharmaceutical storage capacity
at two of its European sites with the construction of two new
warehouses, in answer to increased demand.
Laboratory service provider, LabConnect has announced its
intentions to expand into Central and Eastern Europe by adding
Synevo Medicover Laboratory Services to its LabConnect network,
becoming the first US-based central laboratory...
The world's largest patient recruitment firm, Synexus Clinical
Research has bagged its first Hungarian company in a bid to exploit
the growing clinical trial opportunities in the emerging Eastern
European market.
Croatian drug firm Pliva has sold its Dresden production plant to
Italy's Menarini Group as it tries to recover losses suffered by
its failed venture in proprietor drugs and an end to most of the
royalties it receives.
As contract research organisations (CROs) continue to search for
cost-effective countries in which to operate, the clinical trials
market is increasingly expanding into emerging economies. Central
and Eastern Europe are continuing...
Premier Research has continued its spate of acquisitions this year,
with the latest addition of clinical research organization (CRO)
Imform, which will aid the company's expansion plans into Eastern
Europe.
The consolidation in the generic pharmaceutical industry continues
apace, with companies in the easterly reaches of Europe now getting
in on the act. Czech Republic-headquartered Zentiva has signed an
agreement to acquire 51 per cent...
Leading CRO says it has seen a marked increase in the number of
trials it has been asked to work on in Central Europe, and believes
the trend is set to continue.
